To evaluate the safety and performance of the AltaValve for the treatment of patients with moderate-severe or severe mitral valve regurgitation in subjects who are considered high risk for mortality and morbidity from conventional open-heart surgery.

Please use this link for further information:

clinicaltrials.gov